Suprachoroidal Administration in Subjects With Metastases to the Choroid

ClinicalTrials.gov ID: NCT06643884

Public ClinicalTrials.gov record NCT06643884. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 18, 2026, 6:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Open-Label, Dose Escalation Trial Assessing the Safety, Tolerability, and Treatment Effect of Belzupacap Sarotalocan (AU-011) With Suprachoroidal Administration in Subjects With Metastases to the Choroid

Study identification

NCT ID: NCT06643884
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Aura Biosciences; Industry
Enrollment: 24 participants

Conditions and interventions

Conditions

Interventions

AU-011 Drug
Laser Device
SCS Microinjector Device

Drug · Device

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 15, 2024
Primary completion: Nov 29, 2026
Completion: Oct 30, 2027
Last update posted: Mar 12, 2026

2024 – 2027

United States locations

U.S. sites: 10
U.S. states: 10
U.S. cities: 10

Facility	City	State	ZIP	Site status
Byers Eye Institute at Stanford University	Palo Alto	California	94303	Recruiting
Bascom Palmer Eye Institute	Miami	Florida	33136	Recruiting
Massachusetts Eye and Ear	Boston	Massachusetts	02114	Recruiting
Kellogg Eye Center	Ann Arbor	Michigan	48105	Recruiting
Mayo Clinic	Rochester	Minnesota	55905	Not yet recruiting
Cleveland Clinic, Cole Eye Institute	Cleveland	Ohio	44195	Not yet recruiting
Shields and Shields, PC	Philadelphia	Pennsylvania	19107	Not yet recruiting
Tennessee Retina, PC	Nashville	Tennessee	37203	Recruiting
Retina Consultants of Texas	Bellaire	Texas	77401	Recruiting
University of Washington	Seattle	Washington	98104	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06643884, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 12, 2026 · Synced May 18, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06643884 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →